Satisfying the need for rapid diagnosis of new variant influenza A H1N1

Expert Review of Molecular Diagnostics

Volumn 10, Issue 3, 2010, Pages 251-253

  Van Der Vries, Erhard ^a   Schutten, Martin ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; ANTIVIRUS AGENT; OSELTAMIVIR; VIRUS ANTIGEN; ZANAMIVIR;

ANTIBODY DETECTION; DIAGNOSTIC KIT; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; EDITORIAL; EXTRACORPOREAL OXYGENATION; GENOTYPE; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MEDICAL RESEARCH; PANDEMIC; PATIENT CARE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS CULTURE; VIRUS STRAIN;

ANTIVIRAL AGENTS; DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77950623683     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.10.18     Document Type: Editorial

References (7)

1. Schirmer P, Holodniy M. Oseltamivir for treatment and prophylaxis of influenza infection. Expert Opin. Drug Saf. 8(3), 357-371 (2009).
2. Buxton RC, Edwards B, Juo RR et al. Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir. Anal. Biochem. 280(2), 291-300 (2000).
3. Johnson JA, Li JF, Wei X et al. Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naive populations and associate with reduced treatment efficacy. PLoS Med. 5(7), e158 (2008).
4. Deyde VM, Sheu TG, Trujillo AA et al. Detection of molecular markers of drug resistance in the 2009 pandemic influenza A (H1N1) viruses using pyrosequencing. Antimicrob. Agents Chemother. 54(3), 1102-1110 (2010).
5. van der Vries E, Jonges M, Herfst S et al. Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase. J. Clin. Virol. 47(1), 34-37 (2010).
6. van Asten L, van der Lubben M, van den Wijngaard C et al. Strengthening the diagnostic capacity to detect Bio Safety Level 3 organisms in unusual respiratory viral outbreaks. J. Clin. Virol. 45(3), 185-190 (2009).
7. Meijer A, Beerens A, Claas E et al. Preparing the outbreak assistance laboratory network in The Netherlands for the detection of the influenza virus A (H1N1) variant. J. Clin. Virol. 45(3), 179-184 (2009).